drugset / Trial / NCT07178431
MB-CART2019.1 in Refractory Multiple Sclerosis
NaSingle-groupOpen-labelTreatment
Summary
The goal of this trial is to assess the feasibility, safety and preliminary efficacy of MB-CART2019.1 in patients with active refractory primary and secondary progressive MS.
Timeline
- Start
- 2026-04-01
- Primary completion
- 2030-08-16
- Completion
- 2030-08-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MB-CART2019.1 | Cell therapy | — | — |